Robert Murray McKinnell

Person

Millbrae, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused pyrimidine pyridinone compounds as JAK inhibitors
- Patent number 11,697,648
- Issue date Jul 11, 2023
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 11,420,965
- Issue date Aug 23, 2022
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
- Patent number 11,339,160
- Issue date May 24, 2022
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent number 11,254,655
- Issue date Feb 22, 2022
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitor compound
- Patent number 11,160,810
- Issue date Nov 2, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,988,470
- Issue date Apr 27, 2021
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,968,205
- Issue date Apr 6, 2021
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
- Patent number 10,851,102
- Issue date Dec 1, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent number 10,696,656
- Issue date Jun 30, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,562,894
- Issue date Feb 18, 2020
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,538,513
- Issue date Jan 21, 2020
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
- Patent number 10,392,368
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Erik Fenster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine compound as JAK kinase inhibitor
- Patent number 10,308,646
- Issue date Jun 4, 2019
- Theravance Biopharma R&D IP, LLC
- Jennifer Kozak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent number 10,233,172
- Issue date Mar 19, 2019
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent number 9,975,877
- Issue date May 22, 2018
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,669,027
- Issue date Jun 6, 2017
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent number 9,428,489
- Issue date Aug 30, 2016
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,365,549
- Issue date Jun 14, 2016
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting imidazole antihypertensive agents
- Patent number 9,273,008
- Issue date Mar 1, 2016
- Theravance Biopharma R&D IP, LLC
- Seok-Ki Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of hepatitic C virus
- Patent number 9,260,414
- Issue date Feb 16, 2016
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive...
- Patent number 9,216,970
- Issue date Dec 22, 2015
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,212,168
- Issue date Dec 15, 2015
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine-piperidine compounds as hepatitis C virus inhibitors
- Patent number 9,206,159
- Issue date Dec 8, 2015
- Theravance Biopharma R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting benzoimidazole antihypertensive agents
- Patent number 9,198,899
- Issue date Dec 1, 2015
- Theravance Biopharma R&D IP, LLC
- Paul Allegretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting oxazole antihypertensive agents
- Patent number 9,181,206
- Issue date Nov 10, 2015
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting antihypertensive agents
- Patent number 9,150,514
- Issue date Oct 6, 2015
- Theravance Biopharma R&D IP, LLC
- Paul Allegretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,066,944
- Issue date Jun 30, 2015
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting imidazole antihypertensive agents
- Patent number 9,012,485
- Issue date Apr 21, 2015
- Theravance Biopharma R&D IP, LLC
- Seok-Ki Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive...
- Patent number 8,946,233
- Issue date Feb 3, 2015
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of hepatitis C virus
- Patent number 8,921,372
- Issue date Dec 30, 2014
- Theravance Biopharma R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20240158389
- Publication date May 16, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS
- Publication number 20240092758
- Publication date Mar 21, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20220396573
- Publication date Dec 15, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20220274957
- Publication date Sep 1, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- G01 - MEASURING TESTING
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20220119369
- Publication date Apr 21, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20210214349
- Publication date Jul 15, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS
- Publication number 20210188844
- Publication date Jun 24, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS
- Publication number 20210040085
- Publication date Feb 11, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20200369660
- Publication date Nov 26, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20200283408
- Publication date Sep 10, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS
- Publication number 20200231590
- Publication date Jul 23, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20200216423
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20200046719
- Publication date Feb 13, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190315724
- Publication date Oct 17, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ROBERT MURRAY MCKINNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20190241555
- Publication date Aug 8, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20190152951
- Publication date May 23, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR
- Publication number 20190127364
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- JENNIFER KOZAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS
- Publication number 20190040043
- Publication date Feb 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- ERIK FENSTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20180311255
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20180237420
- Publication date Aug 23, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20170081313
- Publication date Mar 23, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20160038483
- Publication date Feb 11, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Daniel D. Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20150252023
- Publication date Sep 10, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL-ACTING IMIDAZOLE ANTIHYPERTENSIVE AGENTS
- Publication number 20150191435
- Publication date Jul 9, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Seok-Ki Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
- Publication number 20150183761
- Publication date Jul 2, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DUAL-ACTING THIOPHENE, PYRROLE, THIAZOLE AND FURAN ANTIHYPERTENSIVE...
- Publication number 20150105392
- Publication date Apr 16, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL INHIBITORS OF HEPATITIC C VIRUS
- Publication number 20150071878
- Publication date Mar 12, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray McKinnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL-ACTING ANTIHYPERTENSIVE AGENTS
- Publication number 20150065543
- Publication date Mar 5, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul Allegretti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DUAL-ACTING IMIDAZOLE ANTIHYPERTENSIVE AGENTS
- Publication number 20140303222
- Publication date Oct 9, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Seok-Ki Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS
- Publication number 20140194426
- Publication date Jul 10, 2014
- Theravance, Inc.
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Robert Murray McKinnell

Person

Patents Grantslast 30 patents

Fused pyrimidine pyridinone compounds as JAK inhibitors

Pyrimidine compound as JAK kinase inhibitor

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Fused imidazo-piperidine JAK inhibitor compound

Pyrimidine compound as JAK kinase inhibitor

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Imidazole and triazole containing bicyclic compounds as JAK inhibitors

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Pyrimidine compound as JAK kinase inhibitor

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Pyrimidine compound as JAK kinase inhibitor

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Hepatitis C virus inhibitors

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Hepatitis C virus inhibitors

Dual-acting imidazole antihypertensive agents

Inhibitors of hepatitic C virus

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive...

Hepatitis C virus inhibitors

Piperazine-piperidine compounds as hepatitis C virus inhibitors

Dual-acting benzoimidazole antihypertensive agents

Dual-acting oxazole antihypertensive agents

Dual-acting antihypertensive agents

Hepatitis C virus inhibitors

Dual-acting imidazole antihypertensive agents

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive...

Inhibitors of hepatitis C virus

Patents Applicationslast 30 patents

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

FUSED PYRIMIDINE PYRIDINONE COMPOUNDS AS JAK INHIBITORS

IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

IMIDAZOLE AND TRIAZOLE CONTAINING BICYCLIC COMPOUNDS AS JAK INHIBITORS

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

PYRIMIDINE COMPOUND AS JAK KINASE INHIBITOR

PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

HEPATITIS C VIRUS INHIBITORS

HEPATITIS C VIRUS INHIBITORS

DUAL-ACTING IMIDAZOLE ANTIHYPERTENSIVE AGENTS

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

DUAL-ACTING THIOPHENE, PYRROLE, THIAZOLE AND FURAN ANTIHYPERTENSIVE...

NOVEL INHIBITORS OF HEPATITIC C VIRUS

DUAL-ACTING ANTIHYPERTENSIVE AGENTS

DUAL-ACTING IMIDAZOLE ANTIHYPERTENSIVE AGENTS

DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS